TAIM
CVS icon

Te Ahumairangi Investment Management’s CVS Health CVS Stock Holding History

Te Ahumairangi Investment Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.23M Buy
58,906
+5,650
+11% +$435K 0.71% 55
2025
Q4 		$4.23M Sell
53,256
-15,954
-23% -$1.26M 0.76% 49
2025
Q3 		$5.22M Buy
69,210
+2,300
+3% +$158K 0.89% 41
2025
Q2 		$4.62M Buy
66,910
+4,850
+8% +$318K 0.83% 45
2025
Q1 		$4.21M Sell
62,060
-29,802
-32% -$1.78M 0.89% 46
2024
Q4 		$4.12M Sell
91,862
-27,110
-23% -$1.52M 0.86% 49
2024
Q3 		$7.44M Sell
118,972
-4,430
-4% -$258K 1.32% 21
2024
Q2 		$7.29M Buy
123,402
+6,460
+6% +$404K 1.4% 20
2024
Q1 		$9.33M Buy
116,942
+2,180
+2% +$167K 1.62% 17
2023
Q4 		$9.06M Sell
114,762
-36,345
-24% -$2.59M 1.72% 17
2023
Q3 		$10.6M Sell
151,107
-36,260
-19% -$2.57M 1.71% 17
2023
Q2 		$13M Buy
187,367
+33,465
+22% +$2.38M 1.76% 12
2023
Q1 		$11.4M Buy
153,902
+42,275
+38% +$3.54M 1.64% 17
2022
Q4 		$10.4M Buy
111,627
+3,695
+3% +$357K 1.63% 17
2022
Q3 		$10.3M Sell
107,932
-8,525
-7% -$844K 1.75% 14
2022
Q2 		$10.8M Buy
116,457
+5,485
+5% +$535K 1.63% 16
2022
Q1 		$11.2M Sell
110,972
-13,085
-11% -$1.37M 1.53% 20
2021
Q4 		$12.8M Sell
124,057
-2,400
-2% -$222K 1.65% 14
2021
Q3 		$10.7M Buy
126,457
+11,100
+10% +$930K 1.48% 17
2021
Q2 		$9.63M Buy
115,357
+3,000
+3% +$246K 1.26% 23
2021
Q1 		$8.45M Buy
112,357
+1,400
+1% +$102K 1.08% 34
2020
Q4 		$7.58M Buy
110,957
+7,450
+7% +$485K 1.05% 33
2020
Q3 		$6.04M Buy
+103,507
New +$6.44M 1.03% 33

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Te Ahumairangi Investment Management's CVS Position: Q1 2026 in Review

Te Ahumairangi Investment Management increased its CVS Health (CVS) stake by 11% in Q1 2026, buying an estimated $435K and bringing the position to 58,906 shares worth $4.23M. The position accounts for 0.71% of the portfolio, ranked #55.

Te Ahumairangi Investment Management first reported a position in CVS in Q3 2020 and has held it in 23 quarters since. The position peaked at $13M in Q2 2023. 1,873 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Te Ahumairangi Investment Management held 58,906 shares of CVS Health worth $4.23M as of Q1 2026.
  • Te Ahumairangi Investment Management bought 5,650 CVS Health shares in Q1 2026, an estimated $435K.
  • CVS Health made up 0.71% of Te Ahumairangi Investment Management's portfolio in Q1 2026, its #55 holding.
  • Te Ahumairangi Investment Management first reported a position in CVS Health in Q3 2020 and has held it in 23 quarters since.
  • Te Ahumairangi Investment Management's CVS Health position peaked at $13M in Q2 2023.
  • 1,873 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Te Ahumairangi Investment Management's 13F filing for Q1 2026, filed 15 May 2026.